Argitalpenak (194) ALBERTO AMABLE FERNÁNDEZ LUCAS argitalpenak

2024

  1. Sex differences in the progression to Alzheimer’s disease: a combination of functional and structural markers

    GeroScience, Vol. 46, Núm. 2, pp. 2619-2640

  2. The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals without cognitive impairment: a cohort study

    The Lancet Healthy Longevity, Vol. 5, Núm. 4, pp. e276-e286

2023

  1. An approach for prevention planning based on the prevalence and comorbidity of neurodevelopmental disorders in 6-year-old children receiving primary care consultations on the island of Menorca

    BMC Pediatrics, Vol. 23, Núm. 1

  2. Assessment and Comparison of Nonlinear Measures in Resting-State Magnetoencephalograms in Alzheimer's Disease and Mild Cognitive Impairment

    Journal of Alzheimer's disease : JAD, Vol. 96, Núm. 3, pp. 1151-1162

  3. Prevalence, comorbidities, and profiles of neurodevelopmental disorders according to the DSM-5-TR in children aged 6 years old in a European region

    Frontiers in Psychiatry, Vol. 14

  4. Theory of Mind After Acquired Brain Injury: Basic Aspects, Evaluation and Intervention

    Logic, Argumentation and Reasoning (Springer Science and Business Media B.V.), pp. 189-241

2022

  1. Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum

    GeroScience, Vol. 44, Núm. 1, pp. 195-209

  2. Brain signal complexity in adults with Down syndrome: Potential application in the detection of mild cognitive impairment

    Frontiers in Aging Neuroscience, Vol. 14

  3. Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: a systematic review in accordance with the PRISMA criteria

    Child and Adolescent Psychiatry and Mental Health

2021

  1. Hypersynchronized Magnetoencephalography Brain Networks in Patients with Mild Cognitive Impairment and Alzheimer's Disease in down Syndrome

    Brain Connectivity, Vol. 11, Núm. 9, pp. 725-733

  2. Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel

    Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1528-1553

2020

  1. A multivariate model of time to conversion from mild cognitive impairment to Alzheimer’s disease

    GeroScience, Vol. 42, Núm. 6, pp. 1715-1732

  2. Complexity changes in preclinical Alzheimer's disease: An MEG study of subjective cognitive decline and mild cognitive impairment

    Clinical Neurophysiology, Vol. 131, Núm. 2, pp. 437-445

  3. Corrigendum to “Physical activity effects on the individual alpha peak frequency of older adults with and without genetic risk factors for Alzheimer's Disease: A MEG study” [Clin. Neurophysiol. 129 (2018) 1981–1989](S1388245718311507)(10.1016/j.clinph.2018.06.026)

    Clinical Neurophysiology

  4. Emotional Intelligence as an Evolutive Factor on Adult With ADHD

    Journal of Attention Disorders, Vol. 24, Núm. 10, pp. 1462-1470

  5. Paternal and maternal mutations in X-STRs: A GHEP-ISFG collaborative study

    Forensic Science International: Genetics, Vol. 46

  6. Role of Magnetoencephalography in the Early Stages of Alzheimer Disease

    Neuroimaging Clinics of North America, Vol. 30, Núm. 2, pp. 217-227

  7. What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons

    Neurobiology of Aging, Vol. 85, pp. 58-73

2019

  1. Corrigendum: The importance of the validation of m/eeg with current biomarkers in alzheimer's disease (frontiers in human neuroscience, (2019), 13, 10.3389/fnhum.2019.00017)

    Frontiers in Human Neuroscience

  2. Multivariate multiscale dispersion entropy of biomedical times series

    Entropy, Vol. 21, Núm. 9